Search
for
Sort by
Research 61–90 of 262
- Narrative Review: Bioactive Potential of Various Mushrooms as the Treasure of Versatile Therapeutic Natural Product
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Intestinal Lymphatic Biology, Drug Delivery, and Therapeutics: Current Status and Future Directions
- Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy
- Resolution of Recipient-Site Necrosis Following Hair Transplantation in a Patient with Hemangioma: A Case Report and Management Approach
- Southern African HIV Clinicians Society gender-affirming healthcare guideline for South Africa
- Management of psychiatric disorders with HIV and dermatological disorders
- Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment
- Endocrine Management of Adult Gender-Dysphoric/Gender-Incongruent Persons: A Clinical Practice Guideline from Endocrine Society of India
- Aesthetic Rehabilitation Medicine: Enhancing Wellbeing beyond Functional Recovery
- Dermatologic care for lesbian, gay, bisexual, and transgender persons
- Dermatologic care of the lesbian, gay, bisexual and transgender community of India
- INTERFERONS IN DERMATOLOGY
- From bench to babies – drug development for male subfertility
- ALOPESIA AREATA DENGAN TERAPI KOMBINASI INJEKSI PLATELET-RICH PLASMA (PRP) DAN TRIAMSINOLON ASETONID INTRALESI
- Syndromes of Severe Insulin Resistance (SSIRs)
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- The Advances of Broad-Spectrum and Hot Anti-Coronavirus Drugs
- Patient-reported outcomes, provider-reported outcomes, and physiologic parameters after gender-affirming hormone treatment in Canada: a systematic review
- Repurposed Drugs: Current Trends in Drug Discovery
- Drug Repurposing Patent Applications April–June 2021
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Drug repositioning using <i>in silico</i> compound profiling
- Dermatological Drugs, Topical Agents, and Cosmetics
- Alopecia Areata: Current Review
- Complex Regional Pain Syndrome Type I : measurements and treatment
- Anti-inflammatory and anti-hyperplastic effect of Bazhengsan in a male rat model of chronic nonbacterial prostatitis
- Cutaneous drug reactions
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection